| 1 | Etanercepet, rituximab, abatacept, tocilizumab, sarilumab (Kevzara, KEVZARA)
 | 4件: AbataceptAbatacept, Rituximab,
 Sarilumab,
 Tocilizumab
 | 4件: TocilizumabTocilizumab
                
            , Rituximab
                
            ,
 Abatacept
                
            ,
 Sarilumab
                
             (Kevzara, KEVZARA) 💬
 | 4件: CD80CD80, CD86,
 IL6R,
 MS4A1 💬
 | 24件: Allograft rejectionAllograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Graft-versus-host disease, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Rheumatoid arthritis, Systemic lupus erythematosus, Th17 cell differentiation, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Viral protein interaction with cytokine and cytokine receptor, Virion - Adenovirus 💬 | 1件: 4646 💬 | 
| 2 | Kevzara | 1件: SarilumabSarilumab | 1件: SarilumabSarilumab
                
             (Kevzara, KEVZARA) 💬 | 1件: IL6RIL6R 💬 | 11件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 4646 💬 | 
| 3 | Sarilumab (Kevzara, KEVZARA)
 | 1件: SarilumabSarilumab | 1件: SarilumabSarilumab
                
             (Kevzara, KEVZARA) 💬 | 1件: IL6RIL6R 💬 | 11件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 5件: 4141, 46, 84, 107, 271 💬 | 
| 4 | Sarilumab SAR153191 (Kevzara, KEVZARA)
 | 1件: SarilumabSarilumab | 1件: SarilumabSarilumab
                
             (Kevzara, KEVZARA) 💬 | 1件: IL6RIL6R 💬 | 11件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 4141 💬 | 
| 5 | Tocilizumab or sarilumab (Kevzara, KEVZARA)
 | 2件: SarilumabSarilumab, Tocilizumab
 | 2件: TocilizumabTocilizumab
                
            , Sarilumab
                
             (Kevzara, KEVZARA) 💬
 | 1件: IL6RIL6R 💬 | 11件: Coronavirus disease - COVID-19Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬 | 1件: 4646 💬 |